He Zhou, Ph.D.
Affiliations: | 2001 | The University of Mississippi Medical Center, Jackson, MS, United States |
Area:
Immunology, Cell BiologyGoogle:
"He Zhou"Parents
Sign in to add mentor| Melanie Wilson | grad student | 2001 | University of Mississippi Medical Center | |
| (Characterization of channel catfish (Ictalurus punctatus) T cell receptor genes and alloantigen-dependent cytotoxic T lymphocytes.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Xiang R, Liao D, Cheng T, et al. (2011) Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. British Journal of Cancer. 104: 1410-7 |
| Kouwenhoven EN, van Heeringen SJ, Tena JJ, et al. (2010) Genome-wide profiling of p63 DNA-binding sites identifies an element that regulates gene expression during limb development in the 7q21 SHFM1 locus. Plos Genetics. 6: e1001065 |
| Luo YP, Zhou H, Krueger J, et al. (2010) The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression. Oncogene. 29: 662-73 |
| Lewēn S, Zhou H, Hu HD, et al. (2008) A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis. Cancer Immunology, Immunotherapy : Cii. 57: 507-15 |
| Luo Y, Markowitz D, Xiang R, et al. (2007) FLK-1-based minigene vaccines induce T cell-mediated suppression of angiogenesis and tumor protective immunity in syngeneic BALB/c mice. Vaccine. 25: 1409-15 |
| Kaplan CD, Krüger JA, Zhou H, et al. (2006) A novel DNA vaccine encoding PDGFRbeta suppresses growth and dissemination of murine colon, lung and breast carcinoma. Vaccine. 24: 6994-7002 |
| Kruger JA, Kaplan CD, Luo Y, et al. (2006) Characterization of stem cell-like cancer cells in immune-competent mice. Blood. 108: 3906-12 |
| Luo Y, Zhou H, Krueger J, et al. (2006) Targeting tumor-associated macrophages as a novel strategy against breast cancer. The Journal of Clinical Investigation. 116: 2132-2141 |
| Lee SH, Mizutani N, Mizutani M, et al. (2006) Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer. Cancer Immunology, Immunotherapy : Cii. 55: 1565-74 |
| Zhou H, Luo Y, Kaplan CD, et al. (2006) A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor. Blood. 107: 3251-7 |